- Field Trip Health & Wellness (FTHW) adds to the leadership team and schedules the fiscal second quarter 2023 conference call
- Appoints Stacey Hoisak as Senior Vice President, General Counsel, and Dr. Monique Moller as Vice President, Integrative Health
- In addition, the company announced its plans to release financial results for its fiscal 2023 second quarter
- The conference call will be held on Tuesday, November 29, 2022, at 8:30 am ET
- Field Trip Health & Wellness (FTHW) is down 4.35 per cent, trading at C$0.11 at 11:20 am EST
Field Trip Health & Wellness (TSXV:FTHW) has added two senior executives to its leadership team.
The company appointed Stacey Hoisak as Senior Vice President, General Counsel and Dr. Monique Moller as Vice President, Integrative Health.
Ronan Levy, Chairman & CEO, commented, “They bring unique perspectives and extensive track records of working in innovative fields, which will be invaluable as we scale Field Trip by growing our digital communities and expanding access to legal psychedelic-assisted treatments.”
“The addition of Stacey and Monique’s diverse skill sets will effectively round out our executive team and support the execution of our broadened, holistic approach to mental health and wellbeing, which integrates medicine, technology, and community to help people become free from depression and anxiety,” concluded Levy.
Stacey Hoisak is an accomplished corporate/securities lawyer and business leader with more than 20 years of experience.
Most recently, Hoisak held the roles of Chief Executive Officer, Chief Legal Officer, Chief Privacy Officer and Director of Coinsquare Ltd.
Hoisak studied at both the University of New Brunswick (B.Sc (Pre-Med) and LL.B) and Osgoode Hall Law School (Masters in Securities Law).
Dr. Monique Moller is an esteemed physician with expertise in mental health and addiction and is passionate about education, research, and clinical initiatives within the psychedelic field.
Dr. Moller previously served as a staff physician at the Centre for Addiction and Mental Health (CAMH) and the Substance Use Service at Women’s College Hospital and in many academic roles, including Deputy Program Director for the Enhanced Skills Program in Addiction Medicine, Medical Elective Coordinator for Addictions at CAMH, and the Addiction Lead for the Foundations Curriculum in Undergraduate Medical Education at the University of Toronto.
As for her education, Dr. Moller holds a faculty appointment at the University of Toronto as an Assistant Professor in the Division of Mental Health and Addiction, Department of Family and Community Medicine, as well as Pharmacology & Toxicology, and more.
Field Trip would also like to thank Paula Amy Hewitt, who resigned as its Senior Vice President, General Counsel, Chief Privacy Officer and Corporate Secretary, for her years of work.
In addition, the company announced today that it plans to release financial results for its fiscal 2023 second quarter after the market closes on Monday, November 28, 2022.
The company will conduct a conference call to discuss its results the following morning, Tuesday, November 29, 2022, at 8:30 am ET.
Field Trip refers to itself as a center of gravity for the psychedelic renaissance.
Field Trip Health & Wellness (FTHW) is down 4.35 per cent, trading at C$0.11 at 11:20 am EST.
